Hennion & Walsh Asset Management, Inc.
Position in MRK — Merck & Co., Inc.
CIK 1861642
Parsippany, NJ
Position in MRK
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$9,318,177
+$465,676 QoQ
Shares Held
72,515
-1.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#24
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 93.13383437909398.ToString("F0")%
Shared 0.ToString("F0")%
None 6.8661656209060205.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $55,949,166 across 10 Drug Manufacturers - General names. MRK ranks #3 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,360 | $17,223,816 | |
| 2 | JNJ |
Johnson & Johnson
|
43,755 | $11,112,457 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
72,515 | $9,318,177 | |
| 4 | ABBV |
AbbVie Inc.
|
23,832 | $5,997,084 | |
| 5 | GRFS |
Grifols SA
|
592,173 | $4,192,584 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
28,507 | $3,601,574 | |
| 7 | AMGN |
Amgen Inc
|
7,665 | $2,775,649 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
18,045 | $1,039,752 |
All Filings in MRK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,318,177 | 72,515 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $8,852,501 | 73,593 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,299,329 | 78,846 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $6,166,924 | 73,477 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $6,010,777 | 75,932 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,396,566 | 71,263 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $7,441,203 | 74,801 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $7,916,381 | 69,711 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $9,277,076 | 74,936 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $9,900,340 | 75,031 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $9,206,629 | 84,449 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $9,206,921 | 89,431 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $10,209,245 | 88,476 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,290,719 | 87,327 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $9,167,687 | 82,629 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $6,435,489 | 74,727 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,668,356 | 73,142 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $5,419,402 | 66,050 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $5,927,567 | 77,343 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,313,145 | 84,052 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,359,997 | 94,638 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,079,558 | 96,243 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||